Patient Care

SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)

Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated...

Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange

GAITHERSBURG, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting...

Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio

Strategic partnership with Pioneer Veterinary Products Limited expands Zomedica's presence in the UK veterinary market through distribution of its leading...

Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Media ReleaseCOPENHAGEN, Denmark; September 3, 2025 Trial demonstrated the feasibility of treating and monitoring adult patients with relapsed/refractory (R/R) diffuse...

Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections

NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...

Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections

NEW YORK--(BUSINESS WIRE)--Biotia, a health technology company leveraging next-generation sequencing (NGS) and artificial intelligence (AI), and Hospital for Special Surgery...

error: Content is protected !!